Original Research

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

Silverstein BE, Morris TW, Gearinger LS, DeCory HH, Comstock TL

Clinical Ophthalmology 2012, 6:1987-1996

Published Date: 30 November 2012